1. Home
  2. NXGL vs CLGN Comparison

NXGL vs CLGN Comparison

Compare NXGL & CLGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NXGL
  • CLGN
  • Stock Information
  • Founded
  • NXGL 1997
  • CLGN 2004
  • Country
  • NXGL United States
  • CLGN Israel
  • Employees
  • NXGL N/A
  • CLGN N/A
  • Industry
  • NXGL Medical/Dental Instruments
  • CLGN Industrial Specialties
  • Sector
  • NXGL Health Care
  • CLGN Health Care
  • Exchange
  • NXGL Nasdaq
  • CLGN Nasdaq
  • Market Cap
  • NXGL 19.7M
  • CLGN 19.1M
  • IPO Year
  • NXGL 2021
  • CLGN N/A
  • Fundamental
  • Price
  • NXGL $2.65
  • CLGN N/A
  • Analyst Decision
  • NXGL
  • CLGN Strong Buy
  • Analyst Count
  • NXGL 0
  • CLGN 2
  • Target Price
  • NXGL N/A
  • CLGN $11.50
  • AVG Volume (30 Days)
  • NXGL 41.5K
  • CLGN 103.1K
  • Earning Date
  • NXGL 08-13-2025
  • CLGN 08-19-2025
  • Dividend Yield
  • NXGL N/A
  • CLGN N/A
  • EPS Growth
  • NXGL N/A
  • CLGN N/A
  • EPS
  • NXGL N/A
  • CLGN N/A
  • Revenue
  • NXGL $10,228,000.00
  • CLGN $2,472,000.00
  • Revenue This Year
  • NXGL $52.35
  • CLGN $2,177.67
  • Revenue Next Year
  • NXGL $42.38
  • CLGN $56.52
  • P/E Ratio
  • NXGL N/A
  • CLGN N/A
  • Revenue Growth
  • NXGL 116.01
  • CLGN N/A
  • 52 Week Low
  • NXGL $1.95
  • CLGN $1.31
  • 52 Week High
  • NXGL $5.10
  • CLGN $5.48
  • Technical
  • Relative Strength Index (RSI)
  • NXGL 60.17
  • CLGN 41.28
  • Support Level
  • NXGL $2.31
  • CLGN $1.31
  • Resistance Level
  • NXGL $2.78
  • CLGN $1.54
  • Average True Range (ATR)
  • NXGL 0.20
  • CLGN 0.14
  • MACD
  • NXGL 0.04
  • CLGN -0.00
  • Stochastic Oscillator
  • NXGL 74.53
  • CLGN 14.21

About NXGL NexGel Inc

NexGel Inc manufactures high water content, electron beam cross-linked, aqueous polymer hydrogels, or gels, used for wound care, medical diagnostics, transdermal drug delivery, and cosmetics. The company specializes in custom gels by capitalizing on proprietary manufacturing technologies. The gels and consumer products are manufactured using proprietary and non-proprietary mixing, coating and cross-linking technologies.

About CLGN CollPlant Biotechnologies Ltd

CollPlant Biotechnologies Ltd is a regenerative and aesthetic medicine company focused on 3D bioprinting of tissues and organs and medical aesthetics. Its products are based on its rhCollagen (recombinant human collagen) produced with CollPlant's proprietary plant based genetic engineering technology. These products address indications for the diverse fields of tissue repair, aesthetics, and organ manufacturing. The revenues include income from business collaborators and sales of the BioInk product for the development of 3D bioprinting of organs and tissues, sales of rhCollagen for the medical aesthetics market, and sales in Europe of the products for tendinopathy and wound healing. The company operates in United States, which derives key revenue, Canada, Europe and Other, and Israel.

Share on Social Networks: